English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3422]
News [7828]
Articles [63]
Editorials [9]
Conferences [210]
elearning [49]
Lenvatinib and pembrolizumab show promising efficacy in first-line treatment of...
Prof Viktor Grünwald - University Hospital Essen, Essen, Germany
Lenvatinib and pembrolizumab show promising efficacy in first-line treatment of aRCC ( Prof Viktor Grünwald - University Hospital Essen, Essen, Germany )
30 Jan 2024
Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with...
Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA
Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with high-risk biochemically recurrent PC ( Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA )
30 Jan 2024
What's new on ADCs in management of advanced NSCLC
Dr David Planchard - Institute Gustave Roussy, Villejuif, France
What's new on ADCs in management of advanced NSCLC ( Dr David Planchard - Institute Gustave Roussy, Villejuif, France )
25 Jan 2024
Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and...
Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal
Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects ( Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal )
25 Jan 2024
Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR...
Dr Thierry André - Sorbonne Université, Paris, France
Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC ( Dr Thierry André - Sorbonne Université, Paris, France )
24 Jan 2024
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple...
Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy ( Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium )
15 Jan 2024
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer
Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer ( Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya )
10 Jan 2024
The treatment of cervical cancer in the presence of HIV in Sub-Saharan Africa
Dr Ntokozo Ndlovu - University of Zimbabwe, Harare, Zimbabwe
The treatment of cervical cancer in the presence of HIV in Sub-Saharan Africa ( Dr Ntokozo Ndlovu - University of Zimbabwe, Harare, Zimbabwe )
9 Jan 2024
The genomics of cancer in Africa
Prof Solomon Rotimi - Covenant University, Ota, Nigeria
The genomics of cancer in Africa ( Prof Solomon Rotimi - Covenant University, Ota, Nigeria )
3 Jan 2024
SABCS 2023: Highlights
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2023: Highlights ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
2 Jan 2024
Preoperative endocrine therapy in premenopausal women leads to sparing...
Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany
Preoperative endocrine therapy in premenopausal women leads to sparing chemotherapy in additional patients ( Dr Oleg Gluz -  Krankenhaus Bethesda, Mönchengladbach, Germany )
28 Dec 2023
Significant clinical benefits observed with revumenib monotherapy in relapsed...
Dr Ibrahim Aldoss - City of Hope National Medical Center, Duarte, USA
Significant clinical benefits observed with revumenib monotherapy in relapsed/refractory KMT2Ar acute leukaemia ( Dr Ibrahim Aldoss - City of Hope National Medical Center, Duarte, USA )
24 Dec 2023
<1...1516171819...286>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top